Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Hristiana Momchilova Batselova
    Medical Doctor
    Epidemiology of Infectious Diseases and Disaster Medicine
    Medical University, Plovdiv
    Bulgaria
    dr_batselova@abv.bg
    JVI

    Since July 2008, assistant in the Department of Epidemiology, MU- Plovdiv

    From April 2020 epidemiologist at the Hygiene and Epidemiology Department, University Hospital "St. George" EAD

    From September 2022 Acting Head of the Hygiene and Epidemiological Department, University Hospital "St. George" EAD

    On 27.12.2020 applied the first vaccine in the history of the vaccination campaign against COVID-19 in Plovdiv

    In 2021, she was part of the Ministry of Education and Culture of the Republic of Bulgaria campaign to educate teachers about vaccines against COVID-19.

    In 2021-2022 advises on vaccines againstCOVID-19 on the National Patient Helpline toll-free Organization.

    2021-2022 cooperates with the foundation "For our children"

    2021-2023 participated in expert meetings on epidemiology at the Ministry of Health of the Republic of Bulgaria.

    In 2022,  she was part of a working group at the Council of Ministers- Republic of Bulgaria.

    Member of:

    International epidemiological association (IEA) Bacti Vac Network. Bulgarian Scientific Society for Epidemiology of Infectious and Non-Infectious Diseases Bulgarian Association of Preventive Medicine. The South Bulgarian Society of Infectious Diseases, Epidemiology and Parasitology. Bulgarian Association for Prevention and Infection Control.

    Research Interests:

    Vaccines, vaccinology, infectious diseases, emerging diseases, epidemics, pandemics, COVID-19, varicella, shingles, measles.

    List of Publications:

    1. Tomov L, Chervenkov L, Miteva DG, Batselova H, Velikova T. Applications of time series analysis in epidemiology: Literature review and our experience during COVID-19 pandemic. World J Clin Cases. 2023 Oct 16;11(29):6974-6983. doi: 10.12998/wjcc.v11.i29.6974. PMID: 37946767; PMCID: PMC10631421.
    2. Mileva N, Vasilev GH, Ganev B, Chervenkov L, Batselova H, Tzotcheva I, Tomov L, Velikova T, Lazova S. Cardiovascular Manifestations of Multisystem Inflammatory Syndrome in Children: A Single-Center Bulgarian Study. Medicina (Kaunas). 2023 Dec 14;59(12):2175. doi: 10.3390/medicina59122175. PMID: 38138278; PMCID: PMC10744581.
    3. Dimitrov, G., Valkov, T., Batselova, H., Kounchev, O., Momekov, G., Argirova, R. Nationwide analysis of the impact of COVID-19 in patients with a cardiovascular, oncological or chronic pulmonary disease in the context of an Eastern European country with a low vaccination rate, Bulgaria: March 2020-April 2022 (2023) BMJ Open, 13 (8), art. no. e068431,
    4. Miteva, D., Kitanova, M., Batselova, H., Lazova, S., Chervenkov, L., Peshevska-Sekulovska, M., Sekulovski, M., Gulinac, M., Vasilev, G.V., Tomov, L., Velikova, T. The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice (2023) Vaccines, 11 (7), art. no. 1181.
    5. Ivanov N, Krastev B, Miteva DG, Batselova H, Alexandrova R, Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art. World J Clin Oncol. 2023 Sep 24;14(9):343-356
    6. Tomov, L., Batselova, H., Lazova, S., Ganev, B., Tzocheva, I., Velikova, T. Role of children in the Bulgarian COVID-19 epidemic: A mathematical model study (2023) World Journal of Experimental Medicine, 13 (3), pp. 28-46.
    7.  Sekulovski, M. Mileva, N. Vasilev, G.V. Miteva, D. Gulinac, M. Peshevska-Sekulovska, M. Chervenkov, L. Batselova, H. Vasilev, G.H.; Tomov, L.; et al. Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination. Biomedicines 2023, 11, 2813.
    8. Slabakova, Y.; Gerasoudis, S.; Miteva, D.; Peshevska-Sekulovska, M.; Batselova, H.; Snegarova, V.; Vasilev, G.V.; Vasilev, G.H.; Sekulovski, M.; Lazova, S.; et al. SARS-CoV-2 Variant-Specific Gastrointestinal Symptoms of COVID-19: 2023 Update. Gastroenterol. Insights 2023, 14, 431-445. https://doi.org/10.3390/gastroent14040032 .
    9. Tomov, L.P., Batselova, H., Velikova, T.Changes in Patterns of Infectivity and Mortality with SARS-CoV-2 Omicron Variant in Bulgaria.Computer Science and Education in Computer Science. CSECS 2023. Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering, vol 514. Springer, Cham. https://doi.org/10.1007/978-3-031-44668-9_15.
    10. Tomov, L.P., Batselova, H.M., Velikova, T.V. COVID-19 Delta Wave Caused Early Overburden of Hospital Capacity in the Bulgarian Healthcare System in 2021 (2022) Healthcare (Switzerland), 10 (4), art. no. 600.
    11. Tomov, L., Batselova, H., Velikova, T.V. Estimating COVID Case Fatality Rate in Bulgaria for 2020–2021(2022) Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering, LNICST, 450 LNICST, pp. 102-115.
    12. Snegarova V, Miteva D, Gulinac M, Peshevska-Sekulovska M, Batselova H, Velikova T. COVID-19 inpatients with gastrointestinal stromal tumors: Recommendations for management and vaccination. World J Gastrointest Pathophysiol 2022; 13(5): 170-177
    13. Vasilev G, Kabakchieva P, Miteva D, Batselova H, Velikova T. Effectiveness and safety of COVID-19vaccines in patients with diabetes as a factor for vaccine hesitancy. World J Diabetes 2022; 13(9): 738-751.
    14. Miteva D, Peshevska-Sekulovska M, Snegarova V, Batselova H, Alexandrova R, Velikova T. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic. World J Virol 2022; 11(5): 221-236.
    15. Tomov L, Miteva D, Sekulovski M, Batselova H, Velikova T. Pandemic control-do's and don'ts from a control theory perspective. World Journal of Methodology 12.5 (2022): 392.
    16. Velikova, T., Kukov, A., Mihova, A., Snegarova, V., Batselova, H., Nakov, R. Gastrointestinal mucosal immunity and covid-19 (2021) World Journal of Gastroenterology, 27 (30), pp. 5047-5059.
    17. Tomov, L., Velikova, T., Batselova, H. HEALTH RISK MANAGEMENT IN KINDERGARTENS AND SCHOOLS DURING COVID-19 PANDEMIC (2021) General Medicine, 23 (6), pp. 22-27.
    18. Velikova, T., Batselova, H., Jenkov, V. IMPACT OF COVID19 PANDEMIC ON MENTAL HEALTH: A CROSSSECTIONAL SURVEY OF 1,020 BULGARIAN CITIZENS. Bulgarian Journal of Psychiatry (2020), 5 (3) , 10-18.
    19. Velikova TV, Kotsev SV, Georgiev DS, Batselova HM. Immunological aspects of COVID-19: What do we know? World J Biol Chem. 2020 Sep 27;11(2):14-29.
    20. Бацелова Х., Кеворкян А., Райчева Р., Бойкинова О., Балтаджиев И., Шопова Й., Стоилова Й. Епидемиологично проучване на хоспитализираните пациенти с варицела в Пловдивска област за периода 2000-2011г. Обща медицина, 2013, XV (3).
    21. Baltadzhiev, I., Stoilova, J., Popivanova, N., Bazelova, H. Changes in the Viral Hepatitis B (VHB) morbidity 1987-2006 (2009) Problems of Infectious and Parasitic Diseases, 37 (1), pp. 39-40. 
     
    More Info.
    Guoyun Chen
    Assistant Professor
    Department of Pediatrics
    University of Tennessee Health Science Center
    USA
    GChen@childrensnational.org
    JVI

    Research Interest: Self-nonself discrimination in innate immunity, Host-pathogen interactions Autoimmune diseases.

    More Info.
    Li Junwei
    Texas Tech University
    USA
    junwei.li@ttuhsc.edu
    JVI

    Research Interest: My Research Focus on Design Universal and Live Attenuated Influenza Vaccine by using Novel Methods, and Testingthese New Generation Vaccine Candidates in Humanized Mice and Ferrets. As Well, We would like to explore the Mechanism of Cross-Protection induced by live Attenuated Influenza against seasonal and Pandemic Influenza Viruses. Our Results Suggested That Activation of T cell Is Crucial for the cross Protection Stimulated By vaccination With Live Attenuated Influenza Vaccine. In Future Research, We Will Focus on B Cell Development Stimulated by Vaccination with Live Attenuated Influenza vaccine. To Facilitate The Development Of More Effective Vaccines, We Are Also Researching: The Effect Of Current Vaccination Programs On The Epidemiological Changes Of Respiratory Pathogens (Strain Replacement And Antigenic Variation); How People Respond To Infections Or Vaccinations At The Cellular And Molecular Levels (B Cell, T Cell, And Gene expression Levels) identification of New Protective Antigens Through Genomic And Proteomic Approaches.

    More Info.
    Roman Chlibek
    Professor
    Department of Epidemiology
    University of Defence
    Czech Republic
    roman.chlibek@unob.cz
    JVI

    Research Interest: Infection diseases prevention, epidemiology of infectious diseases, vaccination, vaccines, travel and tropical medicine.

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    salvatore.chirumbolo@univr.it
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    Manmohan Singh
    Head
    Global Drug Product Development
    Technical Development Novartis Vaccines
    USA
    manmohan.singh@novartis.com
    JVI

    Research Interest: He focused on developing novel adjuvants and vaccine delivery systems for prophylactic vaccination along with rational design of new vaccine formulations for Novartis discovery projects.

    More Info.
    Om Parkash
    Scientist
    Immunology Laboratory
    National JALMA Institute
    India
    om1234@gmail.com
    JVI

    Research Interest: Complement system, Immunoassays, Proteomics, Biomarkers in diseases, Vaccines, T regulatory cells and diseases, Immunology of leprosy and tuberculosis.

    More Info.
    Mahfoozur Rahman
    Associate Professor
    Department of Pharmaceutics
    Abhilashi College of Pharmacy
    India
    mahfoozkaifi@gmail.com
    JVI

    Research Interest: Immune based inflammatory disorders (with special reference to nanomedicines).

    More Info.
    Bingyun Li
    Professor
    Department of Orthopaedics
    West Virginia University
    USA
    bili@hsc.wvu.edu
    JVI

    Research Interest: Nanomedicine, Controlled/Targeted Drug Delivery, Toxicology, Pharmacology, Cellular Interaction, Nanofilms and Microcapsules, Biomimetic, Microbiology, Immunology.

    More Info.
    Mishra Kamla Prasad
    Department of Allied Sciences
    Defence Institute of Physiology
    India
    kpmpgi@rediffmail.com
    JVI

    Research Interest: Develop treatment modality/Process/Biomarkers for the soldiers working in the extreme conditions. Based on these stressors, different models of stress like hypobaric hypoxia, cold, Isolation (Antarctica) and viral infection are being used to overcome from the stress induced maladies.

    More Info.
    Julie Bouckaert
    Researcher
    Computational Molecular Systems Biology
    Lille University of Science and Technology
    France
    julie.bouckaert@univ-lille1.fr
    JVI

    Research Interest: Structure-to-function relationships of microbial lectins Structural study of multivalent protein-carbohydrate interactions Analysis of differential glycosylation and bacterial infection pathology during metabolic imbalance Structure-based design of anti-bacterial and anti-fungal drugs.

    More Info.
    Liping Jin
    Department of Obstetrics and Gynecology
    Fudan University Shanghai Medical College
    China
    jinlp01@163.com
    JVI

    Research Interest: The keywords of my research interest: Reproductive immunology, Thymic stromal lymphopoietin, The costimulatory signal, Trophoblast, Gamma-delta T cell, CD4+CD25bright regulatory T cell, Pregnancy, Miscarriage, The maternal-fetal immune.

    More Info.
    Karol Fijalkowski
    West Pomerania University of Technology
    Poland
    karol.fijalkowski@zut.edu.pl
    JVI

    Research Interest: Bacteria of the genus Staphylococcus, in particular the species S. aureus and virulence factors produced by this species. In the so far carried out research, the results of which were published in several peer-reviewed journals I analyzed:

    1.The influence of leucocytotoxic and superantygenic virulence factors produced by S. aureus strains isolated from milk of cows with mastitis on the cytokine production and gene expression in bovine leukocyte cultures in vitro;
    2. the impact of staphylococcal exotoxins on the process of phagocytosis in vitro;
    3. the efficacy of treatment of mastitis by staphylococcal autovaccine;
    4. the profile of resistance to methicillin of coagulase-negative staphylococci isolated from animals;
    5. the profile of the genes encoding superantigens in S. aureus and S. xylosus isolates collected from cows;
    6. the possibility of transfer of genes encoding superantigens between staphylococci occurring in the same mammary gland;
    7. genetic relatedness of staphylococci isolated within a herd of animals;
    8. the biological activity of staphylococcal exosecretions against leukocytes in vitro;
    9. the impact of staphylococcal virulence factors on the morphology of leukocytes in vitro.
    I also analyzed and published in the GenBank several new 16S rRNA gene sequences of bacteria representing different species of staphylococci, identified by PCR-RFLP analysis of gap gene. Furthermore, as a contributor I published in the GenBank the 16S rRNA gene sequences of bacterial isolates, which were unidentified based on the polymorphism of gap gene, of which at least two isolates represent new species or subspecies of the staphylococci.
    The second direction of my research concerns the use of magnetic fields, in particular the rotating magnetic field to modify the functional parameters and pathogenicity potential of different species of microorganisms. At the present, I’m analyzing the influence of magnetic field on metabolic processes in microorganisms, both at the cellular and molecular level. As a continuation of my first research mainstream microorganism used in these studies is primarily S. aureus.

    More Info.
    Kuo C SHENG
    Research Fellow
    Griffith University
    Australia
    kuosheng@mail.com
    JVI

    Research Interest: Cancer immunology, vaccines, cancer, antigen-presenting cells and viral immunology.

    More Info.
    Haiqi He
    Southern Plains Agricultural Research Center
    USA
    haiqi.he@ars.usda.gov
    JVI
    More Info.
    View more
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View
    mendeley

    Adult-onset Still’s disease complicated with macrophage activation syndrome: A case report

    DOI Logo 10.17352/jvi.000051

    Published On: July 23, 2022 | Pages: 023 - 028

    Author(s): MNSK Perera* and A Gunapala
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving